Should You Take Statins in Your 30s? ApoB, LDL & Heart Disease Prevention | T. Dayspring & D. Soffer

Atherosclerosis is a ubiquitous condition initiated by the infiltration of ApoB-containing lipoproteins into the arterial wall. This process serves as the necessary substrate for cardiovascular disease, making ApoB a primary target for intervention. Effective management relies on a combination of lifestyle modifications—the "Life's Essential Eight"—and pharmacological therapies, including statins, ezetimibe, and PCSK9 inhibitors. Clinical risk assessment has shifted toward earlier, more aggressive screening, utilizing tools like the Prevent ASCVD Risk Calculator and coronary CT angiography to identify subclinical plaque before major adverse cardiovascular events occur. While genetics and family history significantly influence individual risk, the intensity of lipid-lowering treatment should be tailored to the severity of the underlying disease process. By lowering ApoB levels early and maintaining them over time, clinicians can stabilize or even reverse plaque progression, significantly reducing long-term mortality and morbidity.